Manufacturing Best Practices

November 1st 2023

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

May 25th 2023

This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.

May 15th 2023

Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.

May 9th 2023

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.